Diagnostic and prognostic value of hematological and immunological markers in COVID-19 infection: A meta-analysis of 6320 patients.

Rami M Elshazli Eman Ali Toraih Abdelaziz Elgaml Mohammed Elmowafy Mohamed E El-MeseryMohamed N AminMohammad H HusseinMary T KillackeyManal S FawzyEmad Kandil

Published in: PloS one (2020)

Several hematological and immunological markers, in particular neutrophilic count, could be helpful to be included within the routine panel for COVID-19 infection evaluation to ensure risk stratification and effective management.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
prognostic factors
patient reported outcomes
peripheral blood